Medartis Inc. - United States Revenue and Competitors

Warsaw, IN USA

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Medartis Inc. - United States has 119 Employees.(i)
  • Medartis Inc. - United States grew their employee count by 43% last year.

Medartis Inc. - United States's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M3716%N/AN/A
#2
$15M885%N/AN/A
#3
N/A16128%N/AN/A
#4
N/A11943%N/AN/A
#5
N/A4631%N/AN/A
#6
N/A775%N/AN/A
#7
$3.5M90%N/AN/A
#8
N/A30763%N/AN/A
Add Company

What Is Medartis Inc. - United States?

At Medartis, we develop, manufacture and distribute titanium screws and plates, surgical instruments and system solutions for fracture fixation. Headquartered in Basel, Switzerland, our company is represented worldwide through our eleven subsidiaries and a wide distributor network. We place the highest priority on maintaining stringent quality standards, continuous development and innovation, including comprehensive service provision for physicians, operating-room (OR) staff and patients. Our long-term customer relations based on partnerships have formed the foundation for our sustainable success since the company’s founding. Dr. h.c. Thomas Straumann founded Medartis in 1997 and returned to the field of osteosynthesis in cranio-maxillofacial surgery. Our product portfolio was expanded in 2004 with the APTUS Hand and Distal Radius systems. This paved the way for a successful entry into orthopedics. All Medartis products are developed in close consultation with hand and traumatology specialists as well as experienced OR teams. Our goal is to continually improve early functional rehabilitation through our high-quality products and exclusively developed technologies.

keywords:N/A

N/A

Total Funding

119

Number of Employees

N/A

Revenue (est)

43%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.7M1207%N/A
#2
$13.6M1206%N/A
#3
N/A1218%N/A
#4
$32.7M12148%N/A
#5
$8.8M12223%N/A